Alan’s practice focuses on the representation of biotech, pharma, medical device and other life sciences companies in connection with technology-driven strategic transactions. He advises companies on research collaborations and development agreements, intellectual property and technology licensing agreements, and commercial collaborations, including joint ventures, profit-sharing arrangements and co-promotion agreements. He also has experience with manufacturing, distribution, supply and quality agreements, clinical trial agreements, M&A transactions, and life sciences industry-specific matters and counseling.

Download full bio 


  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 


  • Vanderbilt University Law School
    JD, 1995

  • Bucknell University
    BA, 1992

Admissions & Credentials


New York


Rankings & Accolades

    Legal 500 US: Recommended for Commercial Deals and Contracts (2018)

    Legal 500 US: Recommended for Technology Transactions (2018)